Whitehawk Therapeutics (WHWK) Analyst & Key Data

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts3

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$4.11

Median Target+78.35%

$7.33

Potential upside vs current price

DCF Value-192.92%

-$3.82

Potential downside vs current price

Current Stock Price

$4.11

Median Target+78.35%

$7.33

Potential upside vs current price

DCF Value-192.92%

-$3.82

Potential downside vs current price

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts3

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$4.11

Median Target+78.35%

$7.33

Potential upside vs current price

DCF Value-192.92%

-$3.82

Potential downside vs current price

Current Stock Price

$4.11

Median Target+78.35%

$7.33

Potential upside vs current price

DCF Value-192.92%

-$3.82

Potential downside vs current price

Whitehawk Therapeutics Inc